# Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

> **NCT03135301** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** letrozole plus metformin
- **DRUG:** letrozole

## Key facts

- **NCT ID:** NCT03135301
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-20
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03135301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03135301, "Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03135301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*